Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99
Published March 26, 2025 · Recall initiated: March 5, 2025
Summary
FDA records drug Class II recall D-0277-2025, published March 26, 2025 and initiated March 5, 2025. Recalling firm: Rising Pharma Holding, Inc.; Status: Ongoing; Reported quantity: 1223 bottles; Lot: Lot #: DTB23111A, Exp 8/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Rising Pharma Holding, Inc.
- Distributor
- Nationwide in the USA.
- Lot
- Lot #: DTB23111A, Exp 8/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: RisingJuly 29, 2026
- FDAProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: RisingMarch 11, 2026
- FDACarbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for:October 22, 2025
- FDACinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus,March 26, 2025
- FDAStryker CinchLock Flex Knotless Anchor with Inserter and Suture, REF CAT02643, Sterile EO, Rx Only MR Safe CEMarch 19, 2025
- FDADuloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDCJanuary 15, 2025
Questions about this recall
Was Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99 recalled?
Yes. FDA published recall D-0277-2025 on March 26, 2025. Reported hazard: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
What should I do if I have this product?
Voluntary: Firm initiated · Letter